137 related articles for article (PubMed ID: 23644904)
1. LC-MS/MS assay for the quantitation of the HDAC inhibitor belinostat and five major metabolites in human plasma.
Kiesel BF; Parise RA; Tjørnelund J; Christensen MK; Loza E; Tawbi H; Chu E; Kummar S; Beumer JH
J Pharm Biomed Anal; 2013; 81-82():89-98. PubMed ID: 23644904
[TBL] [Abstract][Full Text] [Related]
2. Validation of an LC-MS/MS method for simultaneous detection of four HDAC inhibitors - belinostat, panobinostat, rocilinostat and vorinostat in mouse plasma and its application to a mouse pharmacokinetic study.
Giri KK; Suresh PS; Saim SM; Zainuddin M; Bhamidipati RK; Dewang P; Hallur MS; Rajagopal S; Rajagopal S; Mullangi R
Biomed Chromatogr; 2017 Jul; 31(7):. PubMed ID: 27925271
[TBL] [Abstract][Full Text] [Related]
3. A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patients.
Wang LZ; Chan D; Yeo W; Wan SC; Chan S; Chan A; Lee SC; Lee HS; Goh BC
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(26):2409-14. PubMed ID: 20724229
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma.
Kiesel BF; Parise RA; Wong A; Keyvanjah K; Jacobs S; Beumer JH
J Pharm Biomed Anal; 2017 Feb; 134():130-136. PubMed ID: 27907855
[TBL] [Abstract][Full Text] [Related]
5. Review of bioanalytical assays for the quantitation of various HDAC inhibitors such as vorinostat, belinostat, panobinostat, romidepsin and chidamine.
Suresh PS; Devaraj VC; Srinivas NR; Mullangi R
Biomed Chromatogr; 2017 Jan; 31(1):. PubMed ID: 27511598
[TBL] [Abstract][Full Text] [Related]
6. LC-MS/MS assay for the quantitation of FdCyd and its metabolites FdUrd and FU in human plasma.
Holleran JL; Eiseman JL; Parise RA; Kummar S; Beumer JH
J Pharm Biomed Anal; 2016 Sep; 129():359-366. PubMed ID: 27454087
[TBL] [Abstract][Full Text] [Related]
7. A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum.
Parise RA; Holleran JL; Beumer JH; Ramalingam S; Egorin MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Aug; 840(2):108-15. PubMed ID: 16725386
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantitation of abiraterone, enzalutamide, N-desmethyl enzalutamide, and bicalutamide in human plasma by LC-MS/MS.
Kim KP; Parise RA; Holleran JL; Lewis LD; Appleman L; van Erp N; Morris MJ; Beumer JH
J Pharm Biomed Anal; 2017 May; 138():197-205. PubMed ID: 28219796
[TBL] [Abstract][Full Text] [Related]
9. Determination of HS270, a new histone deacetylase inhibitor, in rat plasma by LC-MS/MS--application to a preclinical pharmacokinetic study.
Zhong GP; Chen JY; Bi HC; Qin XL; Dai CL; Liu J; Chen X; Zeng GX; Huang ZY; Huang M
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3452-8. PubMed ID: 21983196
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS assay for the quantitation of the ATR kinase inhibitor VX-970 in human plasma.
Kiesel BF; Scemama J; Parise RA; Villaruz L; Iffland A; Doyle A; Ivy P; Chu E; Bakkenist CJ; Beumer JH
J Pharm Biomed Anal; 2017 Nov; 146():244-250. PubMed ID: 28888173
[TBL] [Abstract][Full Text] [Related]
11. Determination of CUDC-101 in rat plasma by liquid chromatography mass spectrometry and its application to a pharmacokinetic study.
Zhang Q; Wen C; Xiang Z; Ma J; Wang X
J Pharm Biomed Anal; 2014 Mar; 90():134-8. PubMed ID: 24366214
[TBL] [Abstract][Full Text] [Related]
12. A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors.
Bailey H; McPherson JP; Bailey EB; Werner TL; Gupta S; Batten J; Reddy G; Bhat G; Sharma S; Agarwal N
Cancer Chemother Pharmacol; 2016 Nov; 78(5):1059-1071. PubMed ID: 27744565
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS assay for the quantitation of the ribonucleotide reductase inhibitor triapine in human plasma.
Matsumoto J; Kiesel BF; Parise RA; Guo J; Taylor S; Huang M; Eiseman JL; Ivy SP; Kunos C; Chu E; Beumer JH
J Pharm Biomed Anal; 2017 Nov; 146():154-160. PubMed ID: 28881312
[TBL] [Abstract][Full Text] [Related]
14. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
15. Quantification of vorinostat and its main metabolites in plasma and intracellular vorinostat in PBMCs by liquid chromatography coupled to tandem mass spectrometry and its relation to histone deacetylase activity in human blood.
Liu L; Detering JC; Milde T; Haefeli WE; Witt O; Burhenne J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():212-21. PubMed ID: 24636840
[TBL] [Abstract][Full Text] [Related]
16. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction.
Takebe N; Beumer JH; Kummar S; Kiesel BF; Dowlati A; O'Sullivan Coyne G; Piekarz R; Rubinstein L; Fogli LK; Vaishampayan U; Goel S; O'Bryant CL; El-Rayes BF; Chung V; Lenz HJ; Kim R; Belani CP; Tuscano JM; Schelman W; Moore N; Doroshow JH; Chen AP
Br J Clin Pharmacol; 2019 Nov; 85(11):2499-2511. PubMed ID: 31271459
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry.
Chavez-Eng CM; Lutz RW; Li H; Goykhman D; Bateman KP; Woolf E
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Feb; 1011():204-14. PubMed ID: 26773885
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of iohexol, a glomerular filtration marker, in human plasma by LC-MS/MS.
Holleran JL; Parise RA; Guo J; Kiesel BF; Taylor SE; Ivy SP; Chu E; Beumer JH
J Pharm Biomed Anal; 2020 Sep; 189():113464. PubMed ID: 32659569
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies.
Chhonker YS; Sleightholm RL; Li J; Oupický D; Murry DJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():320-327. PubMed ID: 29207305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
